AFLIBERCEPT intravitreal injection (Eylea®▼) for Choroidal Neovascularisation - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

AFLIBERCEPT intravitreal injection (Eylea®▼) for Choroidal Neovascularisation

Last Updated: 23 July 2018

Body System: Eye

Red

The Pan Mersey Area Prescribing Committee does not currently recommend the prescribing of AFLIBERCEPT intravitreal injection (Eylea®▼) for the treatment of Choroidal Neovascularisation.